Hereditary motor and sensory neuropathy type 2 (HMSN type 2) is a group of inherited nerve diseases where the long “wires” of the nerves (axons) slowly degenerate. These nerves carry signals from the spinal cord to the muscles (motor) and from the skin to the brain (sensory). Because the axon itself is damaged, signals become weak or lost. Over many years this leads to muscle weakness and wasting in the feet, legs, hands, and sometimes arms, together with numbness or reduced feeling. HMSN type 2 is the classic older name; today it is usually called Charcot-Marie-Tooth disease type 2 (CMT2), and it is classified as an axonal form of CMT. JAMA Network+2NCBI+2
Hereditary motor and sensory neuropathy type 2 is another name for Charcot-Marie-Tooth disease type 2 (CMT2). It is a rare, inherited nerve disease that mainly damages the long “wires” of the peripheral nerves called axons. These nerves carry messages from the brain and spinal cord to the muscles (motor) and from the skin and joints back to the brain (sensory). When the axons slowly degenerate, messages travel poorly, and muscles in the feet, legs, hands, and arms become weak and thin, while feeling in the skin becomes reduced.NCBI+2Europe PMC+2
In hereditary motor and sensory neuropathy type 2, symptoms usually start in childhood or early adult life. People may notice tripping, ankle weakness, high arched feet, curled toes, or loss of balance in the dark. Over time, weakness and numbness can move up the legs and affect the hands, making it hard to do fine tasks like buttoning clothes. Painful burning, tingling, or electric-shock sensations (neuropathic pain) may also appear. There is no cure yet, but many therapies and medicines can ease symptoms, protect joints, and support an active life.Muscular Dystrophy Association+1
In most families, HMSN type 2 is inherited in an autosomal dominant way. This means one changed copy of the gene from one parent is enough to cause the condition, although autosomal recessive patterns also exist in some subtypes. The age when symptoms start can vary a lot, from childhood to late adult life. Progression is usually slow, and many people stay able to walk for decades, although some may need aids such as ankle–foot orthoses or walking sticks later in life. JAMA Network+2Charcot-Marie-Tooth Association+2
Other names
Hereditary motor and sensory neuropathy type 2 is known by several other names in medical books and articles. Knowing these names helps you recognise the same condition when you read or search online:
1. Charcot-Marie-Tooth disease type 2 (CMT2).
This is now the most common name. It honours the three doctors who first described CMT and shows that this is type 2, the axonal form of the disease. NCBI+1
2. Axonal hereditary motor and sensory neuropathy.
This name highlights that the main problem is in the nerve axon (the long fibre) and that both motor and sensory nerves are affected. It separates HMSN type 2 from demyelinating forms where the myelin sheath is mainly damaged. JAMA Network+1
3. Axonal Charcot-Marie-Tooth disease.
Many articles simply use “axonal CMT” to describe the group of CMT2 disorders, including HMSN type 2 and its genetic subtypes. ScienceDirect+1
4. Hereditary axonal sensorimotor neuropathy.
This is a more descriptive name saying that the neuropathy (nerve damage) is inherited, mainly axonal, and affects both feeling (sensory) and movement (motor). Wiley Online Library+1
Types
HMSN type 2 is not a single disease but a family of related axonal neuropathies caused by different genes. Each subtype is usually numbered with a letter after “CMT2”. Here are some important types, written in list form but explained in simple words: Wikipedia+2ScienceDirect+2
1. CMT2A (MFN2-related).
This is the most common axonal CMT. It is caused by mutations in the MFN2 gene, which helps mitochondria (the cell’s power plants) fuse and function properly in neurons. Weakness often starts in childhood or the teen years, with trouble walking and high-arched feet.
2. CMT2B (RAB7-related).
This form is linked to changes in the RAB7 gene, which controls transport of materials inside cells. It often has more severe sensory loss, leading to numb feet and hands and a higher risk of painless injuries.
3. CMT2C (TRPV4-related).
CMT2C may include breathing or vocal cord problems as well as limb weakness, because the gene involved (TRPV4) affects both motor and sensory neurons and sometimes nerves to the diaphragm and larynx.
4. CMT2D (GARS1-related).
This subtype often starts with weakness and wasting in the small hand muscles, making fine movements difficult. It is caused by mutations in GARS1, a gene important for protein synthesis in neurons. Wikipedia+1
5. CMT2E (NEFL-related).
Here the NEFL gene, which encodes a key structural protein in neurons, is affected. People may show early foot deformities, distal weakness, and reduced reflexes, sometimes with mild hearing problems.
6. CMT2F (HSPB1-related).
This type is linked to mutations in a small heat-shock protein gene (HSPB1). It may cause mainly motor symptoms at first, with leg weakness and foot drop, and can overlap with distal hereditary motor neuropathy phenotypes.
7. CMT2I / CMT2J (MPZ-related axonal forms).
Mutations in the MPZ myelin protein gene can sometimes cause an axonal picture rather than a typical demyelinating CMT1 form. These variants are often labelled CMT2I or CMT2J and may have later onset with mixed motor and sensory loss. www.elsevier.com+1
8. CMT2K (GDAP1-related).
GDAP1 mutations can cause either recessive or dominant CMT2. This protein is involved in mitochondrial dynamics and oxidative stress, and its loss tends to produce early-onset distal weakness and sensory loss. PMC+1
9. CMT2N (AARS1-related).
CMT2N is a milder axonal form linked to mutations in a tRNA synthetase gene (AARS1). Symptoms usually begin in the lower legs with slow progression and may be asymmetric. NCBI+1
10. Other rare CMT2 subtypes.
More than 30 CMT2 subtypes have been reported, involving many genes (such as KIF1B, HSPB8, DNM2, MPV17 and others). All share the same basic pattern: inherited axonal degeneration of peripheral nerves leading to distal weakness and sensory loss. Wiley Online Library+2ScienceDirect+2
Causes
Here “causes” mainly mean genetic changes (mutations) that damage axons and produce HMSN type 2 / CMT2. Each item is one important cause or mechanism.
1. MFN2 gene mutations.
Mutations in MFN2 are the most common cause of CMT2. MFN2 helps mitochondria fuse and move along axons. When MFN2 is faulty, mitochondria cluster and fail to reach long nerve endings, so the axon cannot get enough energy and gradually degenerates. IVAMI+1
2. GJB1 (Cx32) gene mutations.
GJB1 encodes connexin-32, a gap junction protein in Schwann cells. Some mutations give an axonal CMT2-like pattern instead of classic demyelinating CMTX. Abnormal connexin channels disturb metabolic support from Schwann cells to axons, contributing to axonal loss. JAMA Network+1
3. GDAP1 gene mutations.
GDAP1 is involved in mitochondrial fission and antioxidant defence. Mutations can cause dominant or recessive axonal CMT2. Impaired GDAP1 function makes axons more sensitive to oxidative stress, leading to early, length-dependent degeneration of peripheral nerves. PMC+2www.elsevier.com+2
4. NEFL gene mutations.
The NEFL gene encodes the neurofilament light chain, one of the main building blocks of the neuronal skeleton. Disease-causing variants disturb neurofilament assembly, making axons unstable and more likely to degenerate, especially in long nerves to the feet and hands. ScienceDirect+1
5. HSPB1 gene mutations.
HSPB1 encodes a small heat-shock protein that protects cells from stress and helps maintain the cytoskeleton. Mutations reduce this protective function and damage microtubules in motor neurons, causing axonal degeneration and distal motor neuropathy with HMSN type 2 features. ScienceDirect+1
6. HSPB8 gene mutations.
HSPB8 is another small heat-shock protein. Disease mutations impair the clearance of misfolded proteins in neurons. This leads to toxic protein buildup, axonal damage, and a phenotype that overlaps CMT2 and distal hereditary motor neuropathy. ScienceDirect+1
7. GARS1 gene mutations.
GARS1 encodes glycyl-tRNA synthetase, an enzyme used in protein building. Mutations do not simply reduce enzyme activity; instead, they cause toxic gain-of-function effects that harm motor and sensory axons, especially in the hands and feet, giving CMT2D. Wikipedia+1
8. AARS1 gene mutations.
AARS1 encodes alanyl-tRNA synthetase. Changes in this gene can lead to CMT2N. Abnormal AARS1 alters translation and cellular stress responses in neurons, slowly damaging long axons and producing distal weakness and sensory loss. NCBI+1
9. TRPV4 gene mutations.
TRPV4 encodes a calcium-permeable ion channel found in many tissues, including neurons. Mutations that over-activate this channel disturb calcium balance inside nerve cells. Chronic calcium overload damages axons and can also affect respiratory and vocal cord nerves in some patients. ScienceDirect+1
10. RAB7 gene mutations.
RAB7 regulates late endosome and lysosome traffic. Mutations disturb the recycling of membrane proteins and growth factor receptors in neurons. This interferes with survival signals along the axon and leads to sensory-predominant axonal neuropathy (CMT2B). ScienceDirect+1
11. MPZ gene mutations with axonal phenotype.
MPZ usually causes demyelinating CMT1, but some specific mutations give an axonal pattern classified as CMT2I or CMT2J. Abnormal myelin protein can secondarily injure the axon, showing how severe myelin defects can evolve into axonal loss. www.elsevier.com+1
12. PMP22 non-duplication variants with axonal damage.
While PMP22 duplication typically causes CMT1A, some rare PMP22 point mutations and deletions may present with mixed or axonal neuropathy, fitting within the HMSN type 2 spectrum. The abnormal PMP22 disrupts Schwann-cell support and harms axons. www.elsevier.com+1
13. KIF1B gene mutations.
KIF1B encodes a kinesin motor protein that moves cargo along microtubules. Mutations reduce axonal transport of mitochondria and synaptic vesicles, so distal axons do not receive enough energy and materials, causing a length-dependent sensorimotor neuropathy. ScienceDirect+1
14. DNM2 gene mutations.
Dynamin-2 (DNM2) is involved in endocytosis and membrane fission. Mutations disturb vesicle formation and cytoskeleton dynamics in neurons. Some variants cause a CMT2-like neuropathy, sometimes with overlapping features of centronuclear myopathy. ScienceDirect+1
15. MPV17 gene mutations.
MPV17 is a mitochondrial inner membrane protein. Mutations impair mitochondrial DNA stability and energy production. Peripheral nerves, which have high energy needs and long axons, are especially vulnerable, resulting in axonal neuropathy similar to HMSN type 2. ScienceDirect+1
16. Other rare axonal-CMT genes.
Many other genes involved in cytoskeleton maintenance, mitochondrial function, and membrane trafficking have been linked to rare CMT2 families. Each adds a small fraction of cases but together they explain why HMSN type 2 is genetically very heterogeneous. Wiley Online Library+2ScienceDirect+2
17. Autosomal dominant inheritance in most families.
In many kindreds, the “cause” at family level is an autosomal dominant mutation passed from an affected parent. Each child has a 50% chance of inheriting the changed gene and therefore the disease, even though onset and severity can vary. JAMA Network+1
18. Autosomal recessive inheritance in some subtypes.
Certain forms, especially those linked to GDAP1 and other genes, follow an autosomal recessive pattern. Here a person must inherit two changed copies (one from each carrier parent). This explains more severe or earlier-onset phenotypes in some HMSN type 2 families. www.elsevier.com+1
19. De novo (new) mutations.
Sometimes a child with HMSN type 2 has a gene mutation that is not present in either parent. This is called a de novo mutation and happens by chance during egg or sperm formation. Once present, the mutation can be passed on to the next generation. MedlinePlus+1
20. Length-dependent axonal vulnerability.
A final “cause” at the nerve level is that very long axons are biologically fragile. They must transport proteins and mitochondria over long distances. Any gene mutation that slightly harms transport, energy production, or cytoskeleton stability will cause the far ends of the axons to fail first, leading to distal neuropathy. NCBI+2ScienceDirect+2
Symptoms
1. Distal leg muscle weakness.
The earliest and most common symptom is weakness in the muscles controlling the ankles and toes. People may find it hard to stand on their heels, climb stairs, or run. This weakness slowly progresses upward over the years. Muscular Dystrophy Association+2Mayo Clinic+2
2. Foot drop and tripping.
Because the front-of-shin muscles become weak, the toes drag when walking, causing “foot drop”. The person may trip over small obstacles and need to lift the knees higher when walking, producing a “steppage” gait. Muscular Dystrophy Association+1
3. Muscle wasting in the lower legs.
Over time, the muscles below the knee become thin because the nerves that control them are damaged. The lower legs can look like “inverted champagne bottles,” with skinny calves and relatively normal thighs. NCBI+1
4. High-arched feet (pes cavus).
Weakness and imbalance of small foot muscles cause the arch to become too high and rigid. This deformity makes shoes uncomfortable, reduces stability, and increases the risk of calluses and ankle sprains. NCBI+1
5. Hammertoes and other toe deformities.
The small muscles that straighten and bend the toes weaken, while stronger tendons pull the toes into bent positions. Hammertoes, claw toes, or overlapping toes may appear, leading to pain, corns, and difficulty finding comfortable footwear. Mayo Clinic+1
6. Distal sensory loss (numbness).
Many people lose feeling in the feet, starting with reduced vibration and light touch, then poor awareness of pain or temperature. Numbness may later affect the hands. This raises the risk of unnoticed injuries and ulcers. Muscular Dystrophy Association+2Mayo Clinic+2
7. Tingling or burning sensations.
Some patients describe unpleasant sensations such as tingling, pins-and-needles, or burning in the feet and hands. These are neuropathic sensory symptoms caused by abnormal firing of damaged axons. Mayo Clinic+1
8. Reduced or absent reflexes.
Deep tendon reflexes, especially at the ankles, become weak or disappear because the reflex arc needs healthy sensory and motor axons. Doctors often notice absent ankle jerks and reduced knee reflexes on examination. Muscular Dystrophy Association+2NCBI+2
9. Poor balance and unsteady walking.
With weak muscles and reduced joint position sense, standing and walking on uneven ground become difficult. People may sway when standing with feet together, especially with eyes closed (positive Romberg sign), and need handrails on stairs. NCBI+1
10. Hand weakness and fine-motor trouble.
As the disease progresses, distal hand muscles can be affected. Tasks like buttoning clothes, writing, using zippers, or opening jars become harder because of weak grip and finger movements. Muscular Dystrophy Association+2Wikipedia+2
11. Fatigue with activity.
Because muscles are weak and nerves work less efficiently, walking long distances or standing for a long time is tiring. People may need frequent rests or mobility aids to help conserve energy during daily tasks. Cleveland Clinic+1
12. Cramps and muscle tightness.
Some individuals experience leg cramps or tight calf muscles, especially after walking. These symptoms arise from abnormal nerve firing and muscle overwork in partly denervated muscles. Cleveland Clinic+1
13. Neuropathic pain in some patients.
Although many people with HMSN type 2 mainly have numbness rather than pain, a proportion develop burning or shooting nerve pain that can affect sleep and mood and may need specific pain management. Mayo Clinic+1
14. Mild skeletal problems (scoliosis or hip issues).
Changes in muscle balance and long-standing weakness can mildly alter posture. Some patients develop scoliosis (curved spine) or hip deformities, especially if onset is in childhood, though this is less common than foot deformities. NCBI+1
15. Slow, lifelong progression.
One of the most important “symptoms” is the very slow course. Weakness and sensory loss worsen gradually over many years. Sudden stepwise worsening suggests another superimposed problem and should prompt medical review. JAMA Network+1
Diagnostic tests
Diagnosis of hereditary motor and sensory neuropathy type 2 combines clinical examination with specialized tests. The goal is to confirm that the neuropathy is axonal, exclude other causes, and identify the exact gene where possible. NCBI+2ScienceDirect+2
Physical exam tests
1. Full neurological examination.
The neurologist checks muscle strength, tone, reflexes, and sensation in all limbs. In HMSN type 2 they typically find distal weakness, muscle wasting, reduced or absent reflexes, and stocking-glove sensory loss, while proximal muscles and cranial nerves are usually relatively preserved. NCBI+2Muscular Dystrophy Association+2
2. Gait and posture assessment.
Watching the patient walk and stand gives key clues. The doctor looks for steppage gait, difficulty walking on heels or toes, ankle instability, and signs of poor balance. They may also note scoliosis or postural compensations linked to long-standing neuropathy. NCBI+1
3. Foot and skeletal examination.
The examiner inspects the feet for high arches, flat feet, hammertoes, calluses, and ankle malalignment, and checks leg length and spinal alignment. These skeletal changes support a chronic, slowly progressive neuropathy starting in childhood or adolescence. NCBI+1
4. Romberg and coordination testing.
Simple bedside tests such as standing with feet together and eyes closed (Romberg), heel-to-shin, and finger-to-nose help check balance and coordination. Difficulty with these tasks in a person with distal sensory loss suggests large-fiber peripheral neuropathy like CMT2. NCBI+1
Manual tests
5. Manual muscle testing (MMT).
The clinician grades strength in different muscle groups by resisting movements with their hands. In HMSN type 2, weakness is usually worse in ankle dorsiflexors, toe extensors, and intrinsic foot and hand muscles, helping to map the pattern of involvement. ScienceDirect+1
6. Vibration sense testing with tuning fork.
A vibrating tuning fork is placed on bony points of the toes and ankles. Reduced or absent perception of vibration indicates large-fiber sensory involvement, which is typical in hereditary motor and sensory neuropathies. NCBI+1
7. Pin-prick and temperature testing.
The doctor gently uses a disposable pin and warm/cool objects to check pain and temperature sensation. In HMSN type 2 these modalities may be mildly to moderately reduced in a stocking-glove pattern, confirming sensory involvement. Muscular Dystrophy Association+1
8. Joint position sense testing.
By moving the toes or fingers up and down with eyes closed and asking the patient to say the direction, the examiner assesses proprioception. Poor joint position sense in the feet supports a large-fiber sensory neuropathy and explains balance problems. NCBI+1
9. Functional hand tests (e.g., peg or button tests).
Simple timed tasks such as placing pegs in holes or buttoning/unbuttoning can be used in clinic to document fine-motor difficulty and hand involvement in more advanced HMSN type 2. ScienceDirect+1
Laboratory and pathological tests
10. Routine blood tests to rule out acquired neuropathies.
Doctors often check blood sugar, vitamin B12, thyroid function, kidney and liver tests, and sometimes autoimmune markers. Normal results make common acquired causes of neuropathy less likely and support a hereditary diagnosis. NCBI+1
11. Targeted genetic testing for common CMT genes.
Once an inherited neuropathy is suspected, molecular testing typically starts with the genes most often involved, such as MFN2 and GJB1 for CMT2, plus other common CMT genes when appropriate. Identifying a pathogenic variant confirms the genetic cause. www.elsevier.com+2IVAMI+2
12. Expanded CMT gene panels or exome sequencing.
If the first tests are negative, broader panels covering many CMT-related genes, or even whole-exome sequencing, can be used. These methods increase the chance of finding rare or novel gene causes in HMSN type 2 families. Wiley Online Library+1
13. Family segregation studies.
When a variant is found, testing other family members helps see if the change tracks with disease. If all affected relatives carry the variant and unaffected ones do not, this strongly supports the variant as the cause. JAMA Network+1
14. Nerve biopsy (usually sural nerve, now used rarely).
In difficult cases, a small sensory nerve can be removed and examined under a microscope. In HMSN type 2 the biopsy shows axonal loss and signs of chronic degeneration. Because genetic testing is now widely available, nerve biopsy is less often needed. JAMA Network+2Wiley Online Library+2
15. Cerebrospinal fluid (CSF) analysis (select cases).
Lumbar puncture with CSF examination is not routine but may be done when an inflammatory neuropathy is suspected. A normal CSF protein level supports a hereditary neuropathy rather than diseases like CIDP, which often raise CSF protein. NCBI+1
Electrodiagnostic tests
16. Nerve conduction studies (NCS).
Small electrical pulses are given to nerves and the responses recorded. In HMSN type 2, conduction velocities are usually normal or only mildly slowed, but the size of the responses (amplitudes) is reduced, showing axonal loss rather than primary demyelination. JAMA Network+2NCBI+2
17. Electromyography (EMG).
A fine needle electrode is inserted into muscles to record their electrical activity. EMG in HMSN type 2 shows chronic denervation and re-innervation patterns, confirming that motor axons are slowly degenerating and that the problem is neuropathic, not muscular. NCBI+1
18. Somatosensory evoked potentials (SSEPs) in special cases.
SSEPs measure how sensory signals travel from the limb to the brain. They can help assess long-sensory pathway function, but are used less often than NCS/EMG and are usually reserved for research or complex diagnostic situations. NCBI+1
Imaging tests
19. X-rays of feet and spine.
Plain radiographs of the feet can show high arches, hammertoes, and joint deformities. Spine X-rays can reveal scoliosis. These images help orthopaedic planning and document long-standing skeletal effects of the neuropathy. NCBI+1
20. MRI or ultrasound of nerves (in selected centres).
High-resolution ultrasound or MRI can visualise peripheral nerves and surrounding tissues. In axonal CMT2, nerve enlargement is usually mild compared with demyelinating CMT1, and imaging is mainly used to exclude other structural causes of neuropathy or foot problems. NCBI+1
Non-pharmacological treatments
1. Structured physiotherapy program
Physiotherapy is one of the most important non-drug treatments for hereditary motor and sensory neuropathy type 2. A trained therapist designs gentle, regular exercises to keep muscles as strong and flexible as possible and to slow stiffness and contractures. Simple movements like stretching, light resistance training, and walking practice can improve balance, walking speed, and stamina. Physiotherapy also teaches safe ways to move, get up from a chair, and climb stairs, to reduce falls and maintain independence.PMC+2nhs.uk+2
2. Individual strength training
Targeted strength training uses low-to-moderate resistance on muscles that are still able to work. The purpose is to slow muscle loss, improve power for walking, standing from a chair, and lifting the feet, and reduce fatigue. The mechanism is simple: repeating small, safe loads over time tells muscles and nerves to work more efficiently. Training must be adapted to each person; over-training weak muscles can cause extra tiredness and soreness, so sessions should be short, regular, and guided by a therapist.Physiopedia+1
3. Daily stretching and range-of-motion exercises
Stretching the ankles, calves, hamstrings, and hands every day helps keep joints from becoming stiff and fixed. The purpose is to prevent contractures, which are permanent shortening of muscles and tendons that make walking and hand use more difficult. Stretching gently lengthens the muscle–tendon unit, improves blood flow, and keeps the joint moving through its full range. It is very important to move slowly, breathe normally, and never force the joint into pain.
4. Balance and gait training
Balance training uses simple tasks like standing on different surfaces, shifting weight, or walking in narrow paths. The purpose is to train the brain and remaining nerves to use vision, inner ear, and joint position sense more effectively to keep the body upright. The mechanism is “neuroplasticity”: repeated practice helps other pathways partly compensate for damaged sensory nerves. Gait training also teaches safer foot placement, wider stance, and use of aids to reduce tripping and falls.
5. Occupational therapy for hand and daily activities
Occupational therapists help people with hereditary motor and sensory neuropathy type 2 manage daily tasks like writing, dressing, cooking, and using tools. The purpose is to keep independence, even when hand weakness and numbness are present. The therapist may suggest special grips, larger handles, button hooks, and energy-saving ways to work. The mechanism is not nerve repair but smart adaptation: by changing tools and techniques, the same task becomes easier and less tiring.
6. Ankle–foot orthoses (AFOs) and braces
Ankle–foot orthoses are light braces that hold the ankle and foot in a stable position. They reduce foot drop, help the toes clear the ground, and make walking smoother and safer. The purpose is to prevent falls, reduce ankle sprains, and allow longer walking distance with less effort. The mechanism is mechanical support: plastic or carbon frames keep the ankle at a right angle and store energy with each step, which then helps lift the foot for the next step.Charcot-Marie-Tooth Association+1
7. Custom shoes and insoles
Custom shoes and insoles spread pressure evenly under the feet, support high arches, and correct some deformities. The purpose is to reduce pain, prevent calluses and ulcers, and improve walking pattern. The mechanism is redistribution of weight: soft materials cushion bony areas, while firmer parts support the arch and heel. For some people, rocker-bottom soles can help the foot roll forward more easily when ankle movement is weak.Mayo Clinic
8. Walking aids (cane, crutches, walker, wheelchair for long distances)
Walking aids give extra points of contact with the ground and make balance easier. The purpose is safety and energy saving: a cane or walker can reduce the risk of sudden falls and allow longer distances with less fatigue. Mechanically, the aid shares body weight with the arms and provides a wider base of support. Some people may use a wheelchair or scooter for long distances but still walk short distances at home, which protects energy and joints.
9. Hydrotherapy and aquatic exercise
Hydrotherapy uses warm water pools for exercise. The water supports body weight and reduces stress on weak ankles and knees, while gentle resistance of water helps strengthen muscles. The purpose is to allow safe, low-impact training even for people who cannot do land-based exercise easily. The mechanism includes buoyancy (less load on joints), warmth (relaxed muscles), and resistance (muscles work as they move through water), which together improve mobility and comfort.
10. Pain management with physical methods
Some people with hereditary motor and sensory neuropathy type 2 have burning or aching pain. Non-drug methods like heat packs, cold packs, massage, gentle stretching, and transcutaneous electrical nerve stimulation (TENS) may give extra relief. The purpose is to reduce pain messages reaching the brain and help muscles relax. The mechanism is “gate control”: mild, non-painful signals from skin and muscles can dampen stronger pain signals in the spinal cord, so pain is felt less intensely.
11. Cognitive-behavioural therapy (CBT) for chronic pain and fatigue
CBT is a talking therapy that helps a person notice and change unhelpful thoughts and behaviors related to pain, fatigue, and disability. The purpose is not to say that pain is “in the mind” but to give tools to cope better, reduce stress, and improve sleep and mood. The mechanism is learning: by using relaxation, pacing, and problem-solving, the brain’s response to pain signals changes, and the overall suffering and disability can fall, even when the nerve damage remains the same.
12. Lifestyle-based aerobic exercise
Regular low-impact aerobic exercise such as walking, stationary cycling, or swimming improves heart and lung fitness and reduces fatigue. For hereditary motor and sensory neuropathy type 2, the aim is to work at a safe level that does not over-tire weak muscles. Aerobic training increases blood flow to nerves and muscles, improves energy use in cells, and supports mental health. Sessions are usually short and frequent, with rest as needed.Physiopedia
13. Weight management and nutrition counselling
Extra body weight puts more load on weak ankles, knees, and hips, making walking and standing harder. Nutrition counselling helps a person choose foods that support a healthy weight, stable blood sugar, and nerve health (such as foods rich in B-vitamins and omega-3 fats). The mechanism is simple: less mechanical stress on joints and better metabolic health can reduce pain, improve stamina, and lower the risk of other diseases like diabetes, which can further damage nerves.
14. Home and workplace modification
Changing the home and workplace can make movement safer and easier. Examples include removing loose rugs, adding grab bars and railings, rearranging furniture for wider paths, using non-slip mats, and raising chair or toilet height. The purpose is to cut the risk of falls and injuries and to allow continued work or study. The mechanism is environmental: by removing hazards and simplifying tasks, the person can function better even with weak muscles and poor sensation.
15. Assistive technology (keyboards, voice software, adapted tools)
Assistive technology includes large-key keyboards, touch screens, voice-to-text software, and adapted kitchen tools. The purpose is to bypass hand weakness and numbness so that school, office work, and hobbies can continue. Mechanically, bigger grips, lighter devices, or voice control reduce the need for fine finger movements. This support can help protect joints from strain, reduce frustration, and maintain social and work roles.
16. Vocational rehabilitation and school support
Vocational rehabilitation specialists help match a person’s abilities with job demands and suggest modifications. For children and teens, school support can include extra time for writing, use of a computer, or help carrying heavy books. The purpose is to keep education and employment possible and satisfying. The mechanism is social and practical: by adjusting tasks and expectations, the person can participate fully despite nerve damage.
17. Psychological support and peer groups
Living with a long-term nerve disorder can cause sadness, anxiety, and worry about the future. Counselling and peer support groups let people share experiences, learn coping skills, and feel less alone. The purpose is emotional health, which strongly affects energy, sleep, and pain perception. The mechanism is supportive communication: when people feel understood and hopeful, stress hormones decrease, and managing daily tasks often becomes easier.
18. Genetic counselling
Genetic counselling explains how hereditary motor and sensory neuropathy type 2 is inherited, what the chances are for children, and what genetic tests are available. The purpose is informed family planning and reduced guilt or confusion. The mechanism is education and risk calculation: by understanding autosomal dominant or other inheritance patterns, families can make thoughtful choices and may join research studies if they wish.NCBI+1
19. Education about safe footwear and skin care
Because feeling in the feet is reduced, small injuries may go unnoticed and turn into ulcers. Teaching people to inspect their feet daily, wear well-fitting closed shoes, and avoid walking barefoot reduces this risk. The mechanism is prevention: by removing pressure points and treating small problems early, infection and bone damage are much less likely.
20. Sleep hygiene and fatigue management
Many people with neuropathy feel tired and sleep poorly due to pain or muscle twitching. Sleep hygiene means going to bed at a regular time, keeping the bedroom dark and quiet, limiting screens before bed, and avoiding heavy meals late at night. The purpose is better, deeper sleep, which supports nerve health, mood, and daytime energy. The mechanism is regulation of the body clock and calming of the nervous system before sleep.
Drug treatments
There is no specific FDA-approved drug that cures hereditary motor and sensory neuropathy type 2. Medicines are used to treat symptoms such as neuropathic pain, muscle cramps, mood problems, and sleep issues. Doses below are typical adult ranges from neuropathic pain or related indications; your own dose may be very different and must be set by a doctor.
1. Gabapentin (Neurontin)
Gabapentin is an anticonvulsant medicine that is widely used to treat neuropathic pain, including painful peripheral neuropathies. FDA labels show it is approved for post-herpetic neuralgia and partial seizures, and similar doses are often used for other nerve pain. A common adult neuropathic-pain dose is 300–1200 mg three times a day, with a maximum of 3600 mg per day, slowly increased by the doctor. Gabapentin reduces the release of excitatory neurotransmitters in pain pathways. Common side effects include dizziness, sleepiness, weight gain, and swelling of the feet.FDA Access Data+2NCBI+2
2. Pregabalin (Lyrica)
Pregabalin is closely related to gabapentin and is approved for several neuropathic pain conditions, including diabetic peripheral neuropathy and post-herpetic neuralgia. Typical adult doses range from 150 to 600 mg per day in two or three divided doses, starting low and increasing according to response and kidney function. It binds to calcium channels in nerve cells and reduces the release of pain-signalling chemicals. Side effects include dizziness, sleepiness, weight gain, ankle swelling, and sometimes blurred vision.
3. Duloxetine (Cymbalta)
Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant that also treats neuropathic pain. FDA labelling and clinical trials show that 60 mg once daily is effective for diabetic peripheral neuropathic pain, and this dose is often used for other neuropathic pain states. Duloxetine increases serotonin and norepinephrine in pain-modulating pathways in the brain and spinal cord, which reduces pain intensity. Common side effects include nausea, dry mouth, sweating, sleep problems, and increased blood pressure in some people.FDA Access Data+2PMC+2
4. Amitriptyline
Amitriptyline is a tricyclic antidepressant used at low doses for chronic neuropathic pain. Typical adult doses start at 10–25 mg at night and may increase to 75–100 mg as tolerated. The drug blocks reuptake of serotonin and norepinephrine and also has antihistamine and anticholinergic effects, which can help sleep but may cause dry mouth or constipation. It aims to reduce burning and shooting pains, improve sleep quality, and lessen the emotional burden of long-term pain.
5. Nortriptyline
Nortriptyline is another tricyclic antidepressant similar to amitriptyline but often better tolerated in some people. Doses commonly start at 10–25 mg at night and may increase up to about 75 mg daily. It acts by increasing serotonin and norepinephrine levels and dampening overactive pain circuits. Side effects can include dry mouth, constipation, blurred vision, and sometimes heart rhythm changes, so ECG checks may be needed in older adults.
6. Carbamazepine
Carbamazepine is an anti-seizure medicine used to treat nerve pain, especially trigeminal neuralgia, and sometimes other neuropathic pains. Typical adult doses are in the range of 400–1200 mg per day in divided doses, carefully adjusted. It stabilizes the inactivated state of sodium channels in nerve cells, which reduces abnormal high-frequency firing. Side effects can include dizziness, nausea, low sodium, and rare but serious blood or liver problems, so blood tests are important.
7. Oxcarbazepine
Oxcarbazepine is related to carbamazepine and can also be used for neuropathic pain in some cases. Adult doses may range from 600–1800 mg per day in divided doses. It blocks sodium channels and reduces excessive nerve firing. Side effects include dizziness, tiredness, double vision, and low sodium levels; it may be better tolerated than carbamazepine for some patients but still needs careful medical monitoring.
8. Topical lidocaine 5% patches
Lidocaine patches are placed on painful areas of skin for up to 12 hours in a 24-hour period. The purpose is local pain relief without strong whole-body side effects. Lidocaine blocks sodium channels in small pain fibres in the skin, reducing the number of pain signals sent to the brain. Side effects are usually mild and include skin redness or irritation under the patch.
9. High-strength capsaicin cream or patch
Capsaicin comes from chili peppers and can be used as a cream or high-dose single-use patch to treat localized neuropathic pain. It works by activating and then desensitizing TRPV1 receptors on pain fibres, which reduces their ability to send pain signals over time. Burning and redness at the application site are common at first but usually decrease with repeated use. It is placed only where the skin is intact and under medical guidance for strong patches.
10. Tramadol
Tramadol is a weak opioid-like medicine that also affects serotonin and norepinephrine reuptake. It may be used for moderate neuropathic pain when first-line drugs are not enough. Typical adult doses are 50–100 mg every 4–6 hours, not exceeding 400 mg per day, but lower doses are used in older adults and kidney or liver disease. Side effects include nausea, dizziness, constipation, and risk of dependence or withdrawal, so it must be used with care.
11. Tapentadol
Tapentadol is a stronger analgesic with both mu-opioid agonist and norepinephrine reuptake inhibition actions. It is used for more severe chronic pain and sometimes neuropathic pain states. Dosing is individualized, often starting at low doses of extended-release tablets and titrated by the doctor. Tapentadol can cause nausea, constipation, dizziness, and carries risks of dependence and respiratory depression, so it is reserved for selected cases under close supervision.
12. Non-steroidal anti-inflammatory drugs (NSAIDs)
Ibuprofen, naproxen, and other NSAIDs are not very effective for pure neuropathic pain but may help with muscle, joint, or ligament pain caused by abnormal gait and deformity. Doses depend on the drug; for example, adults may use ibuprofen 200–400 mg every 6–8 hours with a maximum daily limit, as advised by a doctor. NSAIDs work by blocking cyclo-oxygenase enzymes and lowering prostaglandin levels, reducing inflammation and pain. Side effects include stomach irritation, kidney strain, and increased bleeding risk.
13. Baclofen
Baclofen is a muscle relaxant that acts on GABA-B receptors in the spinal cord. In some people with hereditary motor and sensory neuropathy type 2, it can reduce painful muscle cramps or spasms. Typical adult doses start low, such as 5 mg three times a day, and are slowly increased. Side effects include sleepiness, weakness, and dizziness, so dose increases must be slow and careful.
14. Tizanidine
Tizanidine is another muscle relaxant that works on alpha-2 adrenergic receptors to reduce muscle tone. It can be used for spasticity or severe cramps. Doses start low (e.g., 2–4 mg) and are increased slowly as needed. Side effects include low blood pressure, sleepiness, and dry mouth, so it must be monitored closely and not stopped suddenly.
15. Serotonin reuptake inhibitors (e.g., sertraline)
Depression and anxiety are common in people with chronic nerve disease. SSRIs like sertraline are used to treat mood symptoms rather than neuropathic pain itself, but better mood can reduce the overall burden of pain and fatigue. Doses are individualized, usually starting at a low daily dose and slowly increasing. Side effects can include nausea, headache, and sleep changes.
16. Low-dose benzodiazepines (short term)
In selected cases, a doctor may use a low dose of a benzodiazepine for severe night-time muscle twitching or anxiety that blocks sleep. These drugs enhance GABA, the main inhibitory neurotransmitter, and can calm the nervous system. Because they can cause dependence, confusion, and falls, especially in older adults, they are used at the lowest possible dose and for the shortest possible time.
17. Melatonin (prescription strength in some regions)
Melatonin is a hormone that helps control the sleep–wake cycle. In some countries, higher doses are prescription-only and can be used to improve sleep in chronic illness. It is usually taken 30–60 minutes before bedtime. It helps by signaling to the brain that it is time to sleep and may improve sleep quality with few side effects, although vivid dreams or morning grogginess can occur.
18. Vitamin B12 injections (if deficient)
If laboratory tests show vitamin B12 deficiency, injections can correct this and prevent extra nerve damage on top of hereditary neuropathy. Typical regimens involve frequent injections at first, then monthly maintenance, as directed by the doctor. B12 is required for myelin formation and DNA synthesis in nerve cells. Side effects are usually mild, such as injection-site discomfort.
19. Alpha-lipoic acid (as a prescribed antioxidant in some settings)
Alpha-lipoic acid is an antioxidant used in some countries as a prescription treatment for diabetic neuropathy. It may also be recommended as a supplement in hereditary neuropathies, though evidence is more limited. Common doses in studies range from 300 to 600 mg per day, given orally or by infusion. It may help by reducing oxidative stress and improving blood flow to nerves; side effects include nausea or skin rash.
20. Combination therapy (e.g., gabapentin plus duloxetine)
Many people need more than one drug to control neuropathic pain. Doctors may combine drugs with different mechanisms, such as gabapentin with duloxetine, at lower doses of each. The aim is better pain relief with fewer side effects than high doses of a single drug. The mechanism is additive or sometimes synergistic modulation of different parts of the pain pathway. This must always be guided by a specialist who can watch for interactions.
Dietary molecular supplements
Supplements can interact with medicines. Always discuss doses with a doctor or dietitian, especially for children or teens.
1. Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant made in small amounts by the body and found in foods like spinach and broccoli. In neuropathy research, oral doses around 300–600 mg per day have been studied, especially for diabetic neuropathy. It may reduce oxidative stress in nerves, improve blood flow, and support energy production in mitochondria. Some people notice mild nausea, dizziness, or skin rash. It should be avoided or closely supervised in people with thyroid or blood sugar problems.
2. Acetyl-L-carnitine
Acetyl-L-carnitine helps transport fatty acids into mitochondria, where cells make energy. Doses in studies often range from 500–1000 mg one to three times daily. For hereditary motor and sensory neuropathy type 2, it is used to support nerve energy metabolism and possibly reduce pain and numbness, although evidence is limited. Side effects may include nausea or restlessness. People with thyroid disease or seizures need special caution.
3. Omega-3 fatty acids (fish oil)
Omega-3 fats such as EPA and DHA are found in oily fish and fish oil capsules. Typical supplement doses range from 500–2000 mg combined EPA/DHA per day. These fats reduce inflammation, support cell membranes, and may help nerve function and cardiovascular health. Side effects can include fishy aftertaste, mild stomach upset, or increased bleeding tendency at high doses, especially when combined with blood-thinning drugs.
4. B-complex vitamins (B1, B6, B12)
B-vitamins are essential for nerve function and energy metabolism. Low-to-moderate dose B-complex supplements may contain, for example, 25–100 mg of B1 and B6 and 500–1000 mcg of B12 daily. They support myelin formation, nerve signalling, and red blood cell production. Very high doses of B6 over long periods can actually cause neuropathy, so balanced products and medical guidance are important.
5. Vitamin D
Vitamin D helps with bone strength, immune function, and muscle performance. Many people with chronic conditions have low vitamin D levels. Typical supplements range from 800–2000 IU per day, adjusted after blood tests. Adequate vitamin D may improve muscle strength and reduce falls, and it supports general health. Too much vitamin D can cause high calcium, nausea, and kidney problems, so levels must be checked.
6. Magnesium
Magnesium is involved in muscle relaxation, nerve signalling, and energy production. Supplemental doses often range from 200–400 mg elemental magnesium per day. It may help with muscle cramps and sleep quality in some people with neuropathy. Side effects can include diarrhea or stomach upset, and high doses may be unsafe in kidney disease, so medical advice is needed.
7. Coenzyme Q10 (CoQ10)
CoQ10 is part of the mitochondrial electron transport chain and plays a role in energy production. Doses in studies often range from 100–300 mg per day, taken with food. It is thought to support cells with high energy needs like nerves and muscles and may improve fatigue in some chronic diseases. Side effects are usually mild, such as stomach discomfort or headache.
8. Curcumin (turmeric extract)
Curcumin is the main active compound in turmeric and has anti-inflammatory and antioxidant properties. Supplements often provide 500–1000 mg standardized curcumin daily, sometimes with piperine to improve absorption. It may help reduce inflammation and oxidative stress that can worsen nerve damage. Side effects can include stomach upset, and curcumin may thin the blood, so it must be used carefully with anticoagulant drugs.
9. N-acetylcysteine (NAC)
NAC is a precursor of glutathione, a key antioxidant in the body. Doses in supplements are often 600–1200 mg per day. It can help reduce oxidative stress and may protect nerves from toxic insults in some models. Side effects include nausea, diarrhea, and rarely allergic-type reactions. People with asthma should use it only under medical supervision.
10. Probiotics
Probiotic supplements contain live “good” bacteria that support gut health. Doses are measured in billions of colony-forming units (CFUs), and many products provide 1–20 billion CFU per day. Healthy gut flora may reduce inflammation and improve nutrient absorption, which indirectly supports nerve health and immunity. Side effects are usually mild gas or bloating. Immunocompromised people should discuss probiotics with their doctor first.
Immunity-booster and regenerative / stem-cell-related drugs
At present, regenerative or stem-cell-based drugs for hereditary motor and sensory neuropathy type 2 are experimental. They are not routine treatments and often exist only in clinical trials or animal studies.
1. Intravenous immunoglobulin (IVIG)
IVIG is a blood product made from pooled antibodies from many donors. It is used for some autoimmune neuropathies but is not standard treatment for hereditary motor and sensory neuropathy type 2, which is genetic. In rare cases where a person has both hereditary neuropathy and an autoimmune attack on nerves, IVIG may be given at high doses over several days, repeated every few weeks. It works by modulating the immune system, but dosing and need are decided by specialists only.
2. Corticosteroids (for overlapping immune neuropathy)
Steroids such as prednisone suppress immune activity. They do not repair genetic nerve damage but may be used if doctors suspect a second, immune-mediated neuropathy on top of hereditary disease. Dosing can vary widely, often starting at moderate to high doses and tapering slowly. Long-term use can cause serious side effects like weight gain, diabetes, bone thinning, and infection risk, so they are used very carefully.
3. Experimental gene therapy (AAV-based)
Gene therapy research for CMT2 focuses on correcting or silencing faulty genes (such as MFN2 or GARS1) using viral vectors like adeno-associated virus (AAV). In animal models, these vectors deliver healthy gene copies or tools that adjust gene expression. There is no approved dose or product yet for humans with hereditary motor and sensory neuropathy type 2. Doses are still being tested in trials, and risks include immune reactions and off-target effects.Wikipedia+1
4. Neurotrophic factor-based therapies
Neurotrophic factors such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), or VEGF-related molecules are being explored to support survival of motor and sensory neurons in CMT2. In theory, these molecules stimulate nerve repair, axon growth, and synapse stability. There are no approved dosing regimens yet for hereditary motor and sensory neuropathy type 2; any use is confined to research settings. Side effects and long-term safety are still being studied.
5. Mesenchymal stem cell (MSC) therapies
Some early-phase studies and clinics are exploring the infusion of mesenchymal stem cells from bone marrow, fat, or umbilical cord tissue to support nerve repair. The idea is that MSCs may release growth factors and anti-inflammatory molecules around damaged nerves. There is no standard, proven dose for hereditary motor and sensory neuropathy type 2, and quality of products varies widely. People should be very cautious about commercial stem-cell clinics that are not part of regulated clinical trials.
6. Combined rehabilitation plus experimental biologics
Future approaches may combine structured physiotherapy, orthotics, and occupational therapy with emerging biologic drugs or cell therapies. The purpose is to create a “whole-system” repair environment: exercise and braces maintain joint alignment while biologics try to protect or repair axons. At present, this is a research idea rather than routine care, and there are no fixed dosages. Participation in clinical trials is the safest way to access such treatments.
Surgeries (Procedures and why they are done)
1. Foot deformity correction (osteotomy)
In hereditary motor and sensory neuropathy type 2, high arches and clawed toes can become rigid and painful. Orthopaedic surgeons may cut and reposition bones in the foot (osteotomy) to improve alignment. The aim is to create a flatter, more stable foot that fits into normal shoes and reduces pressure spots and pain. After surgery, physiotherapy and braces are usually needed to protect the improved position.
2. Tendon transfer surgery
Tendon transfer moves the tendon of a stronger muscle to help a weaker one. For example, a tendon from a working muscle can be attached to help lift the front of the foot and reduce foot drop. The purpose is to restore more balanced muscle forces around the ankle and improve the walking pattern. The mechanism is mechanical re-routing: the same muscle power is redirected to a more useful action.
3. Joint fusion (arthrodesis)
When joints such as the ankle or toes are very unstable or painful, surgeons may fuse them into one solid piece of bone. This removes motion at that joint but can greatly improve stability and reduce pain. The procedure is usually considered after braces and less invasive operations have failed. It can make walking safer in severe deformity but reduces flexibility, so careful planning is needed.
4. Nerve decompression (e.g., carpal tunnel release)
People with hereditary motor and sensory neuropathy type 2 may be more prone to entrapment neuropathies like carpal tunnel syndrome because fragile nerves are easily compressed. In these cases, surgery to release the tight tunnel in the wrist can relieve extra pressure on the median nerve. The aim is to reduce pain, numbness, and hand weakness caused by the compression. It does not cure the underlying hereditary neuropathy but removes an added problem.
5. Spinal or lower-limb corrective surgery
Some people develop spinal curvature (scoliosis) or severe knee and hip deformities due to long-standing muscle imbalance. Corrective surgery can straighten the spine or realign joints, helping posture and reducing pain. The purpose is to prevent later breathing problems, improve sitting and standing balance, and make braces or wheelchairs easier to use. These are major operations and require detailed discussion with a specialist team.
Prevention and complication reduction
You cannot prevent the genetic cause, but you can prevent many complications by early diagnosis, regular check-ups, and following therapy plans.
Use proper footwear and orthotics to reduce falls, ankle sprains, and foot ulcers.
Inspect feet daily for cuts, blisters, or color changes and treat small problems early.
Keep an active but safe lifestyle with regular gentle exercise to prevent stiffness, obesity, and heart disease.
Avoid known nerve-toxic medicines (some chemotherapy drugs, high-dose B6, certain antibiotics) unless absolutely needed; always tell doctors you have hereditary neuropathy.
Control other health problems like diabetes, thyroid disease, and vitamin deficiencies, which can further damage nerves.
Maintain a healthy weight to reduce strain on weak legs and feet.
Do home safety checks to remove tripping hazards and install rails or grab bars.
Do not smoke and avoid second-hand smoke, as smoking reduces blood flow to nerves and slows healing.
Use genetic counselling for family planning and early diagnosis of affected family members.
When to see a doctor
You should see a doctor, preferably a neurologist, if you notice new or worsening weakness in your feet, legs, hands, or arms, especially if you start tripping, dropping objects, or cannot climb stairs. You should seek help if pain, burning, or tingling becomes severe or begins to disturb your sleep or daily activities. Any new foot ulcers, skin color changes, or swelling need urgent review, because infections can spread quickly when feeling is reduced.
If you have sudden changes, such as rapid loss of walking ability, trouble breathing, swallowing problems, chest pain, or new bladder or bowel control loss, you should go to an emergency department immediately. Children and teens with suspected hereditary motor and sensory neuropathy type 2 should be assessed early, as braces, physiotherapy, and school support work best when started before major deformities appear. Regular follow-up visits let the care team adjust braces, medicine doses, and therapy plans as your situation changes.
What to eat and what to avoid
Eat plenty of whole plant foods such as fruits, vegetables, whole grains, beans, nuts, and seeds to provide vitamins, minerals, and antioxidants that support nerve and muscle health.
Choose lean proteins like fish, eggs, poultry, tofu, and lentils to help maintain muscle mass, especially in the legs and arms.
Include healthy fats, especially from fish, nuts, seeds, and olive oil, to support cell membranes and reduce inflammation.
Drink enough water through the day to support circulation, digestion, and joint lubrication; limit sugary drinks.
Limit highly processed foods, such as chips, fast food, and packaged snacks, which often contain excess salt, sugar, and unhealthy fats that worsen weight gain and inflammation.
Avoid trans fats and very high saturated fat intake, found in deep-fried foods and some baked goods, because they increase heart disease risk and may harm blood flow to nerves.
Keep added sugar low, as high sugar intake can lead to insulin resistance and diabetes, which can cause additional neuropathy.
Avoid alcohol if you are a teen, and limit alcohol strictly in adults, because heavy drinking can directly damage nerves and worsen balance and falls.
Limit very high-dose single supplements on your own; megadoses, especially of vitamin B6 or certain herbs, can cause toxicity or interact with medicines.
Discuss any special diet (keto, intermittent fasting, etc.) with your doctor, to make sure it is safe for your weight, heart, and nerve health.
Frequently asked questions
1. Is there a cure for hereditary motor and sensory neuropathy type 2?
At the moment there is no cure that can completely stop or reverse the genetic nerve damage. Treatment focuses on symptom control, protecting joints, maintaining strength, and preventing secondary problems. Research into gene therapy and regenerative treatments is ongoing, but these are not yet standard care.
2. Will I definitely need a wheelchair?
Not everyone with hereditary motor and sensory neuropathy type 2 will need a wheelchair. Some people have mild symptoms for life, while others progress more. Early physiotherapy, braces, and careful management can delay or reduce the need for walking aids. Some people use a wheelchair only for long distances to save energy.
3. Does exercise make the disease worse?
Well-planned, gentle exercise usually helps rather than harms. Over-exertion that causes severe pain or days of exhaustion is not helpful, but regular low-impact training strengthens remaining muscles, supports joints, and improves mood and sleep. A physiotherapist can design a safe program for your level.
4. Can children with this disease play sports?
Many children can take part in some sports, especially low-impact activities like swimming or cycling. Contact sports or activities with high fall risk may need to be avoided or modified. A paediatric neurologist and physiotherapist can advise which sports are safest and how to use braces or supports.
5. Is hereditary motor and sensory neuropathy type 2 the same as multiple sclerosis?
No. Multiple sclerosis is an autoimmune disease of the central nervous system (brain and spinal cord). Hereditary motor and sensory neuropathy type 2 is a genetic disease of the peripheral nerves. The symptoms can both involve weakness and balance problems, but the causes, tests, and treatments are different.
6. Can pregnancy worsen hereditary motor and sensory neuropathy type 2?
Many women with this condition have healthy pregnancies. Some notice more fatigue or temporary worsening of walking due to extra weight and fluid. It is important to plan pregnancy with your neurologist and obstetrician, review medicines for safety in pregnancy, and arrange extra support at home.
7. Should my family members be tested?
Because this disease is hereditary, close relatives may want to consider genetic counselling and, in some cases, genetic testing. Whether to test depends on age, symptoms, and personal preferences about knowing genetic information. A genetic counsellor can explain the pros and cons.
8. Can diet alone treat this disease?
Diet cannot change the underlying gene mutation, but healthy eating helps manage weight, energy levels, and general health. Good nutrition supports muscles and nerves and reduces the risk of other diseases that can worsen neuropathy. Diet is one important part of a broader treatment plan.
9. Are stem-cell clinics online safe?
Many commercial stem-cell clinics advertise cures without solid evidence. Some are unregulated and may be unsafe or extremely costly. At this time, stem-cell and gene therapies for hereditary motor and sensory neuropathy type 2 should only be taken as part of well-designed, approved clinical trials.
10. Can I work or study normally with this disease?
Many people can work or study with the help of adaptations like ergonomic chairs, voice-to-text software, flexible hours, and help with lifting or walking long distances. Early occupational therapy and vocational counselling can make a big difference in keeping you active in school or work.
11. Why do my feet look so different?
High arches, claw toes, and thin calves are common in hereditary motor and sensory neuropathy type 2 because certain muscles weaken while others stay strong, pulling bones into new positions. Orthotics, physiotherapy, and sometimes surgery can improve comfort and appearance and make shoe fitting easier.
12. Will medicines for pain make me addicted?
Most non-opioid neuropathic pain medicines such as gabapentin, pregabalin, and duloxetine are not addictive in the same way as street drugs, but they can cause withdrawal symptoms if stopped suddenly. Opioid-type drugs like tramadol carry more risk of dependence. Using them under close medical supervision at the lowest effective dose helps reduce this risk.
13. Can I drive if I have hereditary motor and sensory neuropathy type 2?
Driving depends on leg strength, reaction time, and sensation. Some people can drive safely, sometimes with car adaptations like hand controls. Others may need to stop driving if they cannot brake or steer quickly. A driving assessment center can test this and suggest aids or restrictions.
14. How often should I see my neurologist?
Visit frequency depends on how fast your symptoms change. In stable phases, yearly visits may be enough. If you have new weakness, falls, or pain, or if braces no longer fit well, you may need earlier review. Children usually need more frequent checks because they are growing.
15. Where can I find reliable information and support?
National neurological disease organizations, hereditary neuropathy foundations, and large hospital neuromuscular clinics are good sources of reliable information. Many have websites, printed guides, and online communities. They can also help you find clinical trials and local physiotherapists, orthotists, and counsellors who understand hereditary neuropathies.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 29, 2025.
